ALK has been described in a range of human cancers involved in cancer initiation and progression via activating multiple signaling pathways, such as the PI3K-AKT, CRKL-C3G, MEKK2/3-MEK5-ERK5, JAK-STAT and MAPK signaling pathways 19-23. The gene discussed is RAPGEF1; the disease is cancer.